These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37513935)

  • 1. Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain.
    Zajączkowska R; Pawlik K; Ciapała K; Piotrowska A; Ciechanowska A; Rojewska E; Kocot-Kępska M; Makuch W; Wordliczek J; Mika J
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain.
    Zajączkowska R; Rojewska E; Ciechanowska A; Pawlik K; Ciapała K; Kocot-Kępska M; Makuch W; Wordliczek J; Mika J
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic effects of the novel α
    Murasawa H; Kobayashi H; Saeki K; Kitano Y
    Psychopharmacology (Berl); 2020 Jan; 237(1):189-197. PubMed ID: 31515584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirogabalin activates the descending noradrenergic system by binding to the α
    Oyama M; Watanabe S; Iwai T; Tanabe M
    J Pharmacol Sci; 2021 May; 146(1):33-39. PubMed ID: 33858653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of mirogabalin, a novel ligand for α
    Saeki K; Yasuda SI; Kato M; Kano M; Domon Y; Arakawa N; Kitano Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):723-728. PubMed ID: 30770951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Novel Gabapentinoid Mirogabalin Prevents Upregulation of α2δ-1 Subunit of Voltage-Gated Calcium Channels in Spinal Dorsal Horn in a Rat Model of Spinal Nerve Ligation.
    Domon Y; Kobayashi N; Kubota K; Kitano Y; Ueki H; Shimojo Y; Ishikawa K; Ofune Y
    Drug Res (Stuttg); 2023 Jan; 73(1):54-60. PubMed ID: 36216339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study.
    Tetsunaga T; Tetsunaga T; Nishida K; Misawa H; Takigawa T; Yamane K; Tsuji H; Takei Y; Ozaki T
    J Orthop Surg Res; 2020 May; 15(1):191. PubMed ID: 32456647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effects of the novel α₂δ ligand mirogabalin in a rat model of spinal cord injury.
    Domon Y; Kitano Y; Makino M
    Pharmazie; 2018 Nov; 73(11):659-661. PubMed ID: 30396385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the
    Domon Y; Arakawa N; Inoue T; Matsuda F; Takahashi M; Yamamura N; Kai K; Kitano Y
    J Pharmacol Exp Ther; 2018 Jun; 365(3):573-582. PubMed ID: 29563324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
    Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model.
    Jurga AM; Piotrowska A; Makuch W; Przewlocka B; Mika J
    Front Pharmacol; 2017; 8():48. PubMed ID: 28275350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence.
    Chen EY; Beutler SS; Kaye AD; Edinoff AN; Khademi SH; Stoltz AE; Rueb NR; Cornett EM; Suh WJ
    Anesth Pain Med; 2021 Dec; 11(6):e121402. PubMed ID: 35291398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirogabalin-A Novel Selective Ligand for the α2δ Calcium Channel Subunit.
    Zajączkowska R; Mika J; Leppert W; Kocot-Kępska M; Malec-Milewska M; Wordliczek J
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33572689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin.
    Yamanaka T; Takeshita K; Mochizuki T; Inoue H; Akiyama T
    Spine Surg Relat Res; 2023 Mar; 7(2):136-141. PubMed ID: 37041868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of a new voltage-gated Ca
    Kato J; Inoue T; Yokoyama M; Kuroha M
    Expert Opin Pharmacother; 2021 Dec; 22(17):2311-2322. PubMed ID: 34431423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.
    Bogacka J; Ciapała K; Pawlik K; Kwiatkowski K; Dobrogowski J; Przeklasa-Muszynska A; Mika J
    Front Immunol; 2020; 11():1241. PubMed ID: 32760393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
    Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
    Front Immunol; 2021; 12():781310. PubMed ID: 34795678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally Inspired Molecules for Neuropathic Pain Inhibition-Effect of Mirogabalin and Cebranopadol on Mechanical and Thermal Nociceptive Threshold in Mice.
    Sałat K; Zaręba P; Awtoniuk M; Sałat R
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
    Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study).
    Kimura Y; Yamaguchi S; Suzuki T; Kato J; Chiba S; Hirakawa N; Yamaguchi K; Tanabe Y; Takatsuna H; Kenyoshi Y; Shiosakai K; Sakai M; Iseki M
    Pain Ther; 2021 Jun; 10(1):711-727. PubMed ID: 33856660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.